Sprycel 20mg tablet online | Apple pharmaceuticals

SPRYCEL 20MG

Description: 

Sprycel 20mg is also contains second-generation inhibitor of the oncogenic tyrosine kinase BCR-ABL with 325-fold more potency than imatinib and is also able to inhibit imatinib-resistant BCR-ABL mutants. Sprycel 20mg is a prescription drug which used under the supervision of doctor.

Indication:

Sprycel 20mg is indicated for the treatment of adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.

Mechanism Of Action:

Sprycel 20mg is also contains second-generation inhibitor of the oncogenic tyrosine kinase BCR-ABL with 325-fold more potency than imatinib and is also able to inhibit imatinib-resistant BCR-ABL mutants.
Sprycel 20mg is a prescription drug which used under the supervision of doctor.


 Image result for leukemia cells

Dosage and administration:

Sprycel indicated for Chronic Myeloid Leukaemia:

Newly diagnosed: Used for recently diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in chronic phase initiate 100 mg PO qDay (morning or evening).

Advanced CML:

Used for treatment of chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with support or intolerance to before therapy contains imatinib.

Precautions:

Sprycel will occur Hypokalaemia, hypomagnesemia, congenital QT interval prolongation, hepatic impairment
Sprycel should Use with caution in patients who have or may develop prolongation of QT interval..

For More Information :

Call Us :  +91- 9987711567

Mail to :   applepharmaceutical@gmail.com.

Comments

Popular posts from this blog

velasof, velasof tablets ,uses - Myapplepharma

Today peoples are worried about NSLC – Xovoltib 30mg | Myapplepharma

Sprycel 20mg tablet | Apple pharmaceuticals